A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1).
Pediatr Neurol
; 112: 84-93, 2020 11.
Article
in En
| MEDLINE
| ID: mdl-32942085
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thiadiazoles
/
Enzyme Inhibitors
/
Glycogen Synthase Kinase 3 beta
/
Myotonic Dystrophy
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pediatr Neurol
Journal subject:
NEUROLOGIA
/
PEDIATRIA
Year:
2020
Document type:
Article
Country of publication:
United States